raloxifene hydrochloride has been researched along with verlukast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, M; Jeong, EJ; Lin, H | 1 |
Sun, H; Wang, S; Wu, B; Zhou, X | 1 |
2 other study(ies) available for raloxifene hydrochloride and verlukast
Article | Year |
---|---|
Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cyclosporine; Drug Interactions; Estrogen Antagonists; Estrone; Humans; Intestines; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Propionates; Quinolines; Raloxifene Hydrochloride; Time Factors | 2004 |
Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.
Topics: Arylsulfotransferase; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Diketopiperazines; Enzyme Induction; HEK293 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Metabolic Detoxication, Phase II; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Raloxifene Hydrochloride; RNA Interference; Selective Estrogen Receptor Modulators; Sulfates; Transfection | 2015 |